GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stem Holdings Inc (OTCPK:STMH) » Definitions » Gross-Profit-to-Asset %

Stem Holdings (Stem Holdings) Gross-Profit-to-Asset % : -241.51% (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Stem Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Stem Holdings's annualized Gross Profit for the quarter that ended in Sep. 2023 was $-47.13 Mil. Stem Holdings's average Total Assets over the quarter that ended in Sep. 2023 was $19.52 Mil. Therefore, Stem Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 was -241.51%.


Stem Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for Stem Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stem Holdings Gross-Profit-to-Asset % Chart

Stem Holdings Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 1.47 9.64 12.82 4.82 -

Stem Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.26 0.71 8.51 16.08 -241.51

Competitive Comparison of Stem Holdings's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Stem Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stem Holdings's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stem Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Stem Holdings's Gross-Profit-to-Asset % falls into.



Stem Holdings Gross-Profit-to-Asset % Calculation

Stem Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Sep. 2023 )/( (Total Assets (A: Sep. 2022 )+Total Assets (A: Sep. 2023 ))/ count )
=0/( (30.981+13.347)/ 2 )
=0/22.164
=0.00 %

Stem Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=-47.132/( (25.684+13.347)/ 2 )
=-47.132/19.5155
=-241.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Stem Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Stem Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stem Holdings (Stem Holdings) Business Description

Traded in Other Exchanges
Address
2201 NW Corporate Boulevard, Suite 205, Boca Raton, FL, USA, 33431
Stem Holdings Inc is involved in a cannabis business. The company is engaged in the manufacture, possession, sale, distribution, and branding of cannabis and its related products. Its brand includes TJ's Gardens; Yerba Buena; Cannavore; Dose-ology and Travis X James.
Executives
Matthew Cohen director, officer: CEO & CFO 1702 COSTA DEL SOL, BOCA RATON FL 33432
Brian John Hayek director 7012 GIRARD ST, MCLEAN VA 22101
Diener Robert Louis Benjamin director 41ULUA PLACE, HAIKU HI 96708
Dennis Suskind director ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Rajiv Raj director 438B WOBURN AVE, TORONTO A6 M5M1L7
Jessica Michelle Feingold director 3730 W. 24TH AVE, DENVER CO 80211
Lindy L Sinder director 408 BARGARA LANE, BRYN MAWR PA 19010
Garrett Martin Bender director 506 ANDREWS AVENUE, DELRAY BEACH FL 33483
Adam Berk director, officer: President 9370 GRAND ESTATES WAY, BOCA RATON FL 33496
Steven Shelly Hubbard director, officer: CFO 3496 FARIVIEW WAY, WEST LINN OR 97068